OpenAlex
PricingAboutJobs
Log inGet started
Work

An intra-patient placebo-controlled phase I trial to evaluate the safety and tolerability of intradermal IMM-101 in melanoma

HTML PDF

Year: 2011
Type: article
Study design: Clinical Trial
Source: Annals of Oncology
DOI: 10.1093/annonc/mdr363
Authors: J. Stebbing, A. Dalgleish, A. Gifford-Moore, A. Martin, C. Gleeson, G. Wilson, L.R. Brunet, J. Grange, S. Mudan
Institutions: Imperial College Healthcare NHS Trust, Imperial College London, St George's, University of London, Immodulon Therapeutics (United Kingdom)
Language: English

Topic: Cutaneous Melanoma Detection and Management
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: melanoma, heat-killed mycobacteria, intradermal administration, safety and tolerability, treatment-emergent adverse events, stage IV melanoma, immune activation, cancer immunotherapy
SDG: Good health and well-being

Open Access status: bronze

Funders: Cancer Research UK, National Institute for Health and Care Research
Awards: Translate findings from basic cell biology science into new treatments for cancer., G5640025277
OpenAlex ID: W2119076281
FWCI: 1.459
Cites: 35
Cited by: 59
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security